Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

SGC6870N

SGC6870N is inactive against PRMT6 and can be utilized as a negative control. SGC6870N is an inactive enantiomer of SGC6870 (HY-126300) [1].

Product Specifications

CAS Number

[2561471-15-4]

UNSPSC

12352005

Target

Histone Methyltransferase

Type

Reference compound

Related Pathways

Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/sgc6870n.html

Solubility

10 mM in DMSO

Smiles

O=C(C1=CC=C(Br)S1)N2[C@@H](C3=CC(C)=CC(C)=C3)C4=CC(C)=CC=C4NC(C2)=O

Molecular Formula

C23H21BrN2O2S

Molecular Weight

469.39

References & Citations

[1]Yudao Shen, et al. A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6. J Med Chem. 2021, 64, 7.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Mmu-miR-7051-5p inhibitor
HY-RI03846-01 5 nmol

Mmu-miR-7051-5p inhibitor

Ask
View Details
Mmu-miR-7051-5p inhibitor
HY-RI03846-02 20 nmol

Mmu-miR-7051-5p inhibitor

Ask
View Details
Hars Rat shRNA Plasmid (Locus ID 307492)
TL702928 1 Kit

Hars Rat shRNA Plasmid (Locus ID 307492)

Ask
View Details
Hoxb8, CT (Hoxb8, Hox-2.4, Hoxb-8, Homeobox protein Hox-B8, Homeobox protein Hox-2.4) (FITC)
MBS6307916-01 0.2 mL

Hoxb8, CT (Hoxb8, Hox-2.4, Hoxb-8, Homeobox protein Hox-B8, Homeobox protein Hox-2.4) (FITC)

Ask
View Details
Hoxb8, CT (Hoxb8, Hox-2.4, Hoxb-8, Homeobox protein Hox-B8, Homeobox protein Hox-2.4) (FITC)
MBS6307916-02 5x 0.2 mL

Hoxb8, CT (Hoxb8, Hox-2.4, Hoxb-8, Homeobox protein Hox-B8, Homeobox protein Hox-2.4) (FITC)

Ask
View Details
ZSWIM3 Polyclonal Antibody, APC Conjugated
bs-9138R-APC 100 µL

ZSWIM3 Polyclonal Antibody, APC Conjugated

Ask
View Details